hexoprenaline has been researched along with atosiban in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afschar, P; Bader, A; Bauer, M; Schöll, W; Winter, R | 1 |
| Hrubý, K | 1 |
| Hofmeyr, GJ; Leathersich, SJ; Tran, TS; Vogel, JP | 1 |
1 review(s) available for hexoprenaline and atosiban
| Article | Year |
|---|---|
Acute tocolysis for uterine tachysystole or suspected fetal distress.
Topics: Adrenergic beta-2 Receptor Agonists; Cesarean Section; Female; Fenoterol; Fetal Distress; Hexoprenaline; Humans; Nitroglycerin; Perinatal Death; Pregnancy; Randomized Controlled Trials as Topic; Terbutaline; Tocolysis; Tocolytic Agents; Uterine Contraction; Vasotocin | 2018 |
1 trial(s) available for hexoprenaline and atosiban
| Article | Year |
|---|---|
A prospective randomised trial of atosiban versus hexoprenaline for acute tocolysis and intrauterine resuscitation.
Topics: Adult; Female; Fetal Distress; Hexoprenaline; Humans; Pilot Projects; Pregnancy; Pregnancy Outcome; Prospective Studies; Resuscitation; Tocolytic Agents; Uterine Contraction; Vasotocin | 2004 |
1 other study(ies) available for hexoprenaline and atosiban
| Article | Year |
|---|---|
[Comparison of the cost of treatment of premature labor with atosiban or beta-sympathomimetics from the perspective of the health care payer--a pharmacoeconomic model].
Topics: Czech Republic; Drug Costs; Female; Fenoterol; Health Care Costs; Hexoprenaline; Humans; Insurance, Health, Reimbursement; Models, Economic; Obstetric Labor, Premature; Pregnancy; Randomized Controlled Trials as Topic; Tocolytic Agents; Vasotocin | 2004 |